Our Journals
|
|
|
|
|
AnnouncementsHealth of the Nation Summit: What is your biggest single priority for the new Government? The Lancet invites readers to share their views and concerns on health-care reform. Take part in our pre-event survey. HPV and Cancer — a call for abstracts: submissions due June 7, 2010. |
|
|
|
|
Feature
Thromboprophylaxis after knee replacement
|
The ADVANCE-2 study was designed to evaluate the efficacy and safety of apixaban for preventing venous thromboembolism after elective total knee replacement. Apixaban, an orally active factor Xa inhibitor, may be as effective, have low bleeding risk, and be easier to use than preferred low molecular weight heparins like enoxaparin. Results from the ADVANCE-2 trial are discussed in this week’s podcast. |
Selected Online First articles from The Lancet journals ahead of print publication.
|
Reducing infection-related stillbirths
Review The Lancet (online Mar 10)
|
|
Birth outcomes
Article The Lancet (online Mar 8)
|
|
Migraine with aura
Article The Lancet Neurology (online Mar 4)
|
-
Women’s groups and birth outcomesArticle The Lancet (online Mar 8)
-
Community-associated MRSASeminar The Lancet (online Mar 5)
-
Alzheimer’s diseaseArticle The Lancet Neurology (online Mar 1)
-
ER-/PR-/ERBB2- breast cancerArticle The Lancet Oncology (online Mar 1)
-
Breast cancer profilingArticle The Lancet Oncology (online Feb 23)
-
VEGF targeted therapy in the perioperative settingReview The Lancet Oncology (online Feb 18)
The Lancet's summary of
news and developments across medicine
Earthquake hits
One of the biggest earthquakes in a century, measuring 8•8 on the Richter scale, hit Chile last week, killing at least 708 people, destroying buildings, and triggering a tsunami that threatened Pacific coastlines. President Michelle Bachelet estimated that the economic damage could be up to US$30 billion, equivalent to about 15% of Chile’s gross domestic product.
Road safety
On March 2, the UN General Assembly met to discuss a new resolution on road safety. A proposed plan of action called on member states to tackle rising trends in road traffic deaths and injuries worldwide by increasing resources for road safety, targeting the most common causes of road traffic crashes, and setting targets for reduction of fatalities.
Prescription placebos
The formal licensing and government funding of homoeopathic treatments has been denounced by the UK’s Science and Technology Committee. Lack of evidence of the efficacy of homoeopathic treatments means that they should not be labelled as medicines, the Committee declared. Such actions “lend a spurious medical legitimacy to homeopathic products”.
India’s health budget
In its 2010–11 budget, the Indian Government has earmarked US$4•82 billion for health (an increase of 8•3% from 2009). An annual health survey will be done to map the district health profile of the rural population. AIDS control, mental health programmes, prevention of diabetes and heart disease, and the shortage of health-care workers were all allocated increased funds.
More This Week in Medicine:
Most read in The Lancet journals in January 2010
| 1. |
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Article (2010) Lancet 375 (9711), pp. 283-293
|
| 2. |
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Article (2010) Lancet 375 (9709), pp. 132-140
|
| 3. |
Growth of aid and the decline of humanitarianism
Article (2009) Lancet 375 (9711), pg. 253
|
| 4. |
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Article (2010) Lancet (early online publication)
|
| 5. |
Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08
Article (2010) Lancet (early online publication)
|
Most cited in The Lancet since 1996
| 1. | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Research (1998) Lancet 352 (9131), pp. 837-853
|
| 2. | MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
Research (2002) Lancet 360 (9326), pp. 7-22
|
| 3. | Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Research (1998) Lancet 351 (9118), pp. 1755-1762
|
| 4. | A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
Research (1996) Lancet 348 (9038), pp. 1329-1339
|
| 5. | Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
Research (2001) Lancet 358 (9286), pp. 958-965
|
Letter to the Editor
"Given the important public health and scientific implications, analyses of [seasonal influenza] vaccine’s effect on risk of pandemic H1N1 should be more rigorous."
Listen to summaries of The Lancet journals in mp3 format
Advertisement
